PATSY BUCCINO: Open Payments
NPI 1982673232 · GIRARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 55 payments from 16 companies in 2025. Trend: 2023 $127 · 2024 $541 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $212 |
| PFIZER INC. | 16 | $189 |
| ABBVIE INC. | 9 | $147 |
| Corcept Therapeutics | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Lilly USA, LLC | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: AIRSUPRA, QULIPTA, NURTEC ODT, ELIQUIS, Korlym, REXULTI, MOUNJARO, Auvelity.
Industry payments across OH — which companies pay providers there.
